Business Intelligence

Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.

Company behind popular Ōura Ring files paperwork for IPO
Details are slim, but Ōura Health confirmed it submitted a draft registration with the Securities and Exchange Commission. The company received $900 million in new funding from investors in October.
CVS sues Tennessee in latest challenge to state PBM laws
The same day that Tennessee Gov. Bill Lee signed a bill that would force pharmacy benefit managers to divest from retail pharmacies, CVS Health filed a lawsuit to block its implementation.
Nationwide private-equity backed hospital chain announces shift to nonprofit business model
Quorum Health said the move will allow it to save money through tax exemptions and provide its 11 hospitals with access to the 340B Drug Pricing Program. The health system is majority-owned by Goldentree Asset Management.
Medtronic acquires non-opioid nerve pain treatment company for $650M
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
Medicare Advantage grows into a $10B-plus opportunity for go-getter brokers selling plans for private insurers
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.

Edwards Lifesciences Corporation has shared new one-year data on the safety and effectiveness of its Evoque transcatheter tricuspid valve replacement (TTVR) system among patients with tricuspid regurgitation (TR)

CMS approves Medicare coverage for transcatheter tricuspid valve replacement

CMS will cover TTVR for the treatment of symptomatic tricuspid regurgitation on a national level. The agency first proposed such a policy in December, taking time to consider public comments before finalizing its decision.

Clinical support tool for pediatric autism earns $27M from private equity

Motivity is receiving an injection of cash from Five Elms Capital, a software investment firm. The companies said the funds will be used to hire staff and improve products.

Job staffing interview waiting resume hiring workforce

Private equity buyouts increase physician turnover by 265%, study finds

A study by researchers at Brown University and Duke University analyzed the employment records of 200 practices acquired by private equity firms and compared them with unacquired practices to develop some observations.

Healthcare AI newswatch: Ambient AI costs, healthcare AI holdouts, an 86-year-old AI innovator, more

Meet an 86-year-old IT entrepreneur who recently beefed up his AI skills in a challenging postgraduate program.

Vintage neon drug sign at the Walgreens pharmacy on Canal Street in downtown New Orleans.

Walgreens $10B private equity buyout financed by 83% debt

A filing with the U.S. Securities and Exchange Commission reveals details on how Sycamore Partners intends to pay for the struggling pharmacy chain.

Walgreens confirms $10B sale to PE, as part of $24B transaction

Sycamore Partners will be purchasing the struggling pharmacy chain for $11.45 a share and putting its VillageMD clinics up for sale.

Healthcare AI newswatch: Does healthcare AI need DEI? | Insider AI risk | 2025 Turing Prize | more

If U.S. healthcare is to help advance responsible and ethical AI for all communities, it very much needs to continue prioritizing DEI initiatives.

CEO of Amazon’s One Medical steps down

Trent Green served in the role since September 2023. He’s leaving to take the helm at a data analytics firm.

Business Intelligence

Company behind popular Ōura Ring files paperwork for IPO

CVS sues Tennessee in latest challenge to state PBM laws

Nationwide private-equity backed hospital chain announces shift to nonprofit business model

Medtronic acquires non-opioid nerve pain treatment company for $650M

Medicare Advantage grows into a $10B-plus opportunity for go-getter brokers selling plans for private insurers